Post by BioDuro

26,706 followers

πŸ§ͺIn drug discovery, reactions that work at milligram scale often fail to translate at production scale. Relying solely on discovery chemistry for scale-up is a high-risk approach that can lead to low yields, safety concerns, and costly delays. This is where π——π—Άπ˜€π—°π—Όπ˜ƒπ—²π—Ώπ˜† π—£π—Ώπ—Όπ—°π—²π˜€π˜€ π—–π—΅π—²π—Ίπ—Άπ˜€π˜π—Ώπ˜† (𝗗𝗣𝗖) plays a critical role. At BioDuro, our DPC team bridges discovery and development. We don’t simply scale up reactions. We develop synthetic routes designed for robustness, safety, and cost-efficiency from the outset. By identifying scale-up liabilities early, we help accelerate time to clinic while reducing overall development costs. #DrugDiscovery #ProcessChemistry #MedicinalChemistry #DrugDevelopment #RouteDesign

Post contentPost contentPost content